Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · IEX Real-Time Price · USD
1.290
+0.120 (10.26%)
Jul 22, 2024, 11:20 AM EDT - Market open
Virax Biolabs Group Employees
Virax Biolabs Group had 11 employees as of March 31, 2023. The number of employees increased by 6 or 120.00% compared to the previous year.
Employees
11
Change (1Y)
6
Growth (1Y)
120.00%
Revenue / Employee
$7,209
Profits / Employee
-$629,412
Market Cap
2.76M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2023 | 11 | 6 | 120.00% |
| Mar 31, 2022 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TC Biopharm (Holdings) | 41 |
| ASLAN Pharmaceuticals | 35 |
| INVO Bioscience | 30 |
| FOXO Technologies | 29 |
| Petros Pharmaceuticals | 21 |
| Altamira Therapeutics | 10 |
| Alzamend Neuro | 7 |
| CNS Pharmaceuticals | 5 |
VRAX News
- 3 months ago - Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024 - PRNewsWire
- 3 months ago - Virax Biolabs to Participate at ESCMID Global 2024 - PRNewsWire
- 4 months ago - Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency - PRNewsWire
- 7 months ago - Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients - PRNewsWire
- 7 months ago - Virax Biolabs' CEO James Foster Issues Letter to Shareholders - PRNewsWire
- 7 months ago - Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation - PRNewsWire
- 11 months ago - Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar - PRNewsWire
- 11 months ago - Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum - PRNewsWire